Carregant...
Mitigating risk in academic preclinical drug discovery
The number of academic drug discovery centres has grown considerably in recent years, providing new opportunities to couple the curiosity-driven research culture in academia with rigorous preclinical drug discovery practices used in industry. To fully realize the potential of these opportunities, it...
Guardat en:
| Publicat a: | Nat Rev Drug Discov |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6002840/ https://ncbi.nlm.nih.gov/pubmed/25829283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd4578 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|